IN-VITRO ACTIVITY OF FK-037, A NOVEL PARENTERAL CEPHALOSPORIN, AGAINST BACTERIAL ISOLATES FROM NEUTROPENIC CANCER-PATIENTS

被引:4
|
作者
DHOLAKIA, N [1 ]
ROLSTON, KVI [1 ]
HO, DH [1 ]
LEBLANC, B [1 ]
STREETER, H [1 ]
DVORAK, T [1 ]
BODEY, GP [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MED SPECIALTIES,INFECT DIS SECT,HOUSTON,TX 77030
关键词
D O I
10.1007/BF01974000
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in vitro activity of FK-037, a novel parenteral cephalosporin, was compared fo that of ceftazidime, aztreonam and piperacillin (agents often used in empiric regimens in cancer patients) against recent bacterial isolates from patients with cancer. FK-037 was either equal to or 2 to 16-fold more active than the comparative agents against members of the Enterobacteriaceae. It was also active against Acinetobacter spp., Aeromonas spp., Pseudomonas aeruginosa, and other Pseudomonas spp. Xanthomonas maltophilia and Alcaligenes denitrificans were relatively resistant to ah four agents. FK-037 was also 4 to 16-fold more active against mesa gram-positive organisms (including some methicillin-resistant staphylococci) than was ceftazidime. Enterococcus spp., Listeria monocytogenes and Staphylococcus haemolyticus were relatively resistant to FK-037 and ceftazidime. Overall, FK-037 has a broad antimicrobial spectrum that includes the majority of gram-positive and gram-negative isolates.
引用
收藏
页码:679 / 685
页数:7
相关论文
共 50 条
  • [41] INVITRO ACTIVITY OF SPARFLOXACIN (CI-978, AT-4140) AGAINST CLINICAL ISOLATES FROM CANCER-PATIENTS
    ROLSTON, KVI
    NGUYEN, H
    MESSER, M
    LEBLANC, B
    HO, DH
    BODEY, GP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) : 2263 - 2266
  • [42] COMPARATIVE INVITRO ACTIVITY OF CEFPIROME (HR 810) AGAINST GRAM-POSITIVE ISOLATES FROM CANCER-PATIENTS
    ROLSTON, KVI
    BODEY, GP
    INFECTION, 1986, 14 (03) : 139 - 141
  • [43] INVITRO ACTIVITY OF TROSPECTOMYCIN (U-63366F), A NOVEL SPECTINOMYCIN ANALOG, AGAINST GRAM-POSITIVE ISOLATES FROM CANCER-PATIENTS
    ROLSTON, K
    HO, DH
    BODEY, GP
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (03) : 254 - 256
  • [44] Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates
    Deshpande, L
    Rhomberg, PR
    Fritsche, TR
    Sader, HS
    Jones, RN
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (01) : 73 - 75
  • [45] In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany
    Seifert, Harald
    Koerber-Irrgang, Barbara
    Kresken, Michael
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (02) : 227 - 234
  • [46] IN-VITRO ACTIVITIES OF ANTIMICROBIAL AGENTS AGAINST CLINICAL ISOLATES OF FLAVIMONAS-ORYZIHABITANS OBTAINED FROM PATIENTS WITH CANCER
    ROLSTON, KVI
    HO, DH
    LEBLANC, B
    BODEY, GP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) : 2504 - 2505
  • [47] INVITRO ACTIVITY OF SCH-34343, A NEW PENAM, AGAINST GRAM-POSITIVE ISOLATES FROM CANCER-PATIENTS
    ROLSTON, KVI
    ALVAREZ, ME
    HOY, JF
    ALDERMAN, HC
    HO, DH
    BODEY, GP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (02) : 159 - 162
  • [48] Activity of Cefiderocol and Comparators against Isolates from Cancer Patients
    Rolston, Kenneth V. I.
    Gerges, Baghat
    Shelburne, Samuel
    Aitken, Samuel L.
    Raad, Issam
    Prince, Randall A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (05)
  • [49] In Vitro Antimicrobial Activity of Quinolones Against Major Bacterial Isolates from the Ocular Surface Bacterial Flora of Tertiary Hospital Patients in Japan
    Eguchi, Hiroshi
    Nishida, Koichi
    Hotta, Fumika
    Shimomura, Yoshikazu
    Kusaka, Shunji
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 37 (02) : 84 - 89
  • [50] The in vitro activity of delafloxacin and comparator agents against bacterial pathogens isolated from patients with cancer
    Gerges, Bahgat
    Rolston, Kenneth
    Shelburne, Samuel A.
    Rosenblatt, Joel
    Prince, Randall
    Raad, Issam
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (02):